Year: 2014
Type: article
Abstract: Histone deacetylase inhibitors (HDACis) are known to exert immunomodulatory effects. We have recently demonstrated that the therapeutic efficacy of HDACis against aggressive B-cell lymphoma and colon carcinoma relies on a functional immune system, in particular on the production of interferon γ (IFNγ). Our findings provide a rationale for the combination of HDACis with immunotherapeutic agents in the clinic.
Source: OncoImmunology
DOI: 10.4161/onci.27414
Authors: Alison C West, Mark J Smyth, Ricky W Johnstone
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,913
OpenAlex ID: W2011664887
